Abstract:The degradation of fluoroquinolones (FQs) via advanced oxidation processes (AOPs) is a promising avenue, yet the complete mineralization of certain FQ molecules remains elusive, raising concerns about the formation of toxic by-products. This study delineates five primary AOP degradation pathways for 16 commercially available FQ molecules, inferred from existing literature. Density functional theory (DFT) was employed to calculate the bond dissociation energies within these pathways to elucidate the correlation between bond strength and molecular architecture. Subsequently, Comparative Molecular Similarity Index Analysis (CoMSIA) models were constructed for various degradation reactions, including piperazine ring cleavage, defluorination, hydroxylation, and piperazine ring hydroxylation. Three-dimensional contour maps generated from these models provide a deeper understanding of the interplay between FQ molecular structure and bond dissociation energy. Furthermore, toxicity predictions for 16 FQ molecules and their advanced oxidation intermediates, conducted using VEGA 1.2.3 software, indicate that degradation products from pathways P2 and P5 pose a heightened health risk relative to their parent compounds. Furthermore, the application of the Multwfn program to compute the Fukui function for FQ molecules discerns the disparity in degradation propensities, highlighting that N atoms with higher f0 values can augment the likelihood of piperazine ring cleavage. HOMO-LUMO distribution diagrams further confirm that methoxy substitution at the 1-position leads to a dilution of HOMOs on the piperazine ring and an increased energy gap for free radical reactions, diminishing the reactivity with hydroxyl radicals. This study elucidates the pivotal role of structural characteristics in FQ antibiotics for their degradation efficiency within AOPs and unveils the underlying mechanisms of bond dissociation energy disparities. The toxicity parameter predictions for FQ molecules and their intermediates offer unique perspectives and theoretical underpinnings for mitigating the use of high-risk FQs and for devising targeted degradation strategies to circumvent the generation of toxic intermediates in AOPs through molecular structure optimization.

Theoretical insights into the degradation mechanisms, kinetics and eco-toxicity of oxcarbazepine initiated by OH radicals in aqueous environments

Efficient Degradation Of Carbamazepine In Aqueous Solution By Bismuth Oxybromide-Activated Peroxide Oxidation

Degradation of Oxcarbazepine by UV-activated Persulfate Oxidation: Kinetics, Mechanisms, and Pathways

Insight into the generation of toxic by-products during UV/H 2 O 2 degradation of carbamazepine: Mechanisms, N-transformation and toxicity

Reactive Oxygen Species Generated in Situ During Carbamazepine Photodegradation at 222 nm Far-UVC: Unexpected Role of H2O Molecules

Mechanistic insights into UV photolysis of carbamazepine and caffeine: Active species, reaction sites, and toxicity evolution

Ciprofloxacin transformation in aqueous environments: Mechanism, kinetics, and toxicity assessment during •OH-mediated oxidation

Reactive Oxygen Species Generated in Situ During Carbamazepine Photodegradation at 222 nm Far-UVC: Unexpected Role of H 2 O Molecules

Effective degradation of carbamazepine using a novel electro-peroxone process involving simultaneous electrochemical generation of ozone and hydrogen peroxide

Insights of Electrocatalytic Oxidation Mechanisms Utilizing Different Oxidants for Degradation of Organic Pollutants: Option for Sustainability

The degradation pathways of carbamazepine in advanced oxidation process: A mini review coupled with DFT calculation

Ozonation of carbamazepine, diclofenac, sulfamethoxazole and trimethoprim and formation of major oxidation products

Theoretical investigation on the transformation of ketamine initiated by ⋅OH/SO 4 − ⋅ in aqueous solution: mechanisms, kinetics and ecotoxicity assessment

Identification and Mechanistic Analysis of Toxic Degradation Products in the Advanced Oxidation Pathways of Fluoroquinolone Antibiotics

Degradation of Pharmaceuticals in UV/H2O2 Process: EEM-based Kinetic Model, Transformation Products and Corresponding Toxicity Evaluation

Ozonolysis of ketoprofen in polluted water: Reaction pathways, kinetics, removal efficiency, and health effects

Insights into catalytic activation of peroxymonosulfate for carbamazepine degradation by MnO2 nanoparticles in-situ anchored titanate nanotubes: Mechanism, ecotoxicity and DFT study

New Insights into the Degradation Mechanism of Ibuprofen in UV/H2O2 Process: Role of Natural Dissolved Matter in Hydrogen Transfer Reactions

Mechanistic insight into the degradation of 1H-benzotriazole and 4-methyl-1H-benzotriazole by •OH-based advanced oxidation process and toxicity assessment

Synergistically enhanced heterogeneous activation of dissolved oxygen for aqueous carbamazepine degradation over S(III) coupled with siderite

Degradation of diclofenac by advanced oxidation and reduction processes: kinetic studies, degradation pathways and toxicity assessments.